Investigating the Effect of Herbal Medicine Nasal Irrigation on Treatment of Chronic Rhinitis and Sinusitis

June 18, 2020 updated by: Chang Gung Memorial Hospital

Chia Yi Chang Gung Memorial Hospital

This study investigate the nasal irrigation with Traditional herbal medicine extract-saline isotonic solution in the treatment of chronic rhinitis and sinusitis. Half of participants will receive Traditional herbal medicine extract-saline isotonic solution nasal irrigation, while the other half will receive saline alone nasal irrigation.

Study Overview

Detailed Description

In the program, the investigators plan to investigate a clinical triad to research the outcomes of nasal irrigation with Traditional herbal medicine extract-saline isotonic solution for treatment of chronic rhinitis and sinusitis. The aims of this study are listed below:

Aim 1: evaluating the outcomes and quality of life of nasal irrigation with Traditional herbal medicine extract-saline isotonic solution to treat enrolled patients with chronic rhinitis or sinusitis. The investigators use modern devices to evaluate the autonomic nerve, meridian energy and pulse. The questionnaires of quality of life and symptoms will be recorded. Nasal irrigation with saline alone will be conducted during the clinical triad to compare the effectiveness and quality of life with Traditional herbal medicine extract.

Aim 2: analyzing the changes of bacteria culture in nasal discharge collected during the clinical triad before and after nasal irrigation for investigating the microenvironment of Traditional herbal medicine extract-saline isotonic solution.

According to the research, the investigators will realize the improvement of using Traditional herbal medicine extract-saline isotonic solution for nasal irrigation to treat sino-nasal diseases, by investigating the changes of quality of life and microenvironment of nasal cavity. The nasopharyngoscopic examination, autonomic nerve, meridian energy and pulse were record to compare the effectiveness of Traditional herbal medicine extract-saline isotonic solution with nasal irrigation with saline alone.

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chiayi City, Taiwan
        • Recruiting
        • Chang Gung Memorial Hospital
        • Contact:
          • Pei-Rung Yang
          • Phone Number: 2069 +886-5-3621000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diagnostic criteria for chronic rhinitis and sinusitis male and female volunteers.
  2. Stop using oral and topical steroid and anti-histamine treatments >2 weeks prior to enrollment.
  3. >20 years of age.

Exclusion Criteria:

  1. Allergy to herbal medicine.
  2. Presence of a sinus tumor.
  3. Significant immune dysfunction.
  4. Pregnancy and breast-feeding women.
  5. Undergone nasal surgery <1 week prior to enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Traditional Chinese Medicine(TCM) group
nasal irrigation with Traditional herbal medicine(licorice) extract-saline isotonic solution
measure autonomic nerve
measure meridian energy
use culture swab to culture nasal discharge
use nasopharyngoscopy to determine the modified Lund-Kennedy endoscopic scoring system
Chinese herbal medicine (licorice) extract solution with buffered salt packet and water in rinse bottle
Placebo Comparator: Saline control group
nasal irrigation with saline isotonic solution
measure autonomic nerve
measure meridian energy
use culture swab to culture nasal discharge
use nasopharyngoscopy to determine the modified Lund-Kennedy endoscopic scoring system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WHOQOL-brief score (Taiwan version)
Time Frame: one month
consisting of 28 items, each scored from 1 to 5; total score recorded as the sum of all items change from baseline: the questionnaires of quality of life
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
22-item Sino-Nasal Outcome Test score (SNOT-22)
Time Frame: one month
consisting of 22 items, each scored from 0 to 5; total score recorded as the sum of all items, 0 to 110 change from baseline: the questionnaires of chronic sinusitis severity
one month
Total symptom score(TSS)
Time Frame: one month
consisting of 4 items, each scored from 0 to 3; total score recorded as the sum of all items, 0 to 12 change from baseline: the questionnaires of chronic rhinitis severity
one month
Autonomic nerve (HRV)
Time Frame: one month
Low frequency (ms2), High frequency (ms2), LF/HF(indicate autonomic function) change from baseline
one month
Meridian energy
Time Frame: one month
Yang energy and Yin energy change from baseline
one month
Posttreatment culture negativity
Time Frame: one month
negative" means if no bacterial pathogen is identified on posttreatment culture but at least one has been present on pretreatment culture
one month
Nasopharyngoscopic examination change
Time Frame: one month
consisting of 3 items, each scored from 0 to 2; total score recorded as the sum of both side all items, 0 to 12 change from baseline
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Pei-Rung Yang, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 31, 2019

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Anticipated)

February 14, 2022

Study Registration Dates

First Submitted

August 5, 2019

First Submitted That Met QC Criteria

August 5, 2019

First Posted (Actual)

August 6, 2019

Study Record Updates

Last Update Posted (Actual)

June 22, 2020

Last Update Submitted That Met QC Criteria

June 18, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 201801970A3

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nasal Disease

Clinical Trials on Taiwan Scientific" noninvasive blood pressure meter TS-0411

Subscribe